Understanding Fluidized-Bed Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Understanding Fluidized-Bed Granulation
This study demonstrates the beneficial use of a spatial-filter velocimetry particle-size analyzer during granulation.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 63-67

References

1. S.M. Iveson, et al., Powder Technol. 117 (1–2), 3–39 (2001).

2. T. Naervanen, et al., AAPS PharmSciTech 9 (1), 282–287 (2008).

3. S. Watano, Powder Technol. 117 (1–2), 163–172 (2001).

4. S. Watano and K. Miyanami, Powder Technol. 83 (1), 55–60 (1995).

5. S. Watano et al., Chem. Pharm. Bull. 48 (8), 1154–1159 (2000).

6. S. Watano et al., Powder Technol. 115 (2), 124–130 (2001).

7. S. Watano, Y. Sato, and K. Miyanami, Chem. Pharm. Bull. 44 (8), 1556–1560 (1996).

8. S. Watano, Y. Sato, and K. Miyanami, Adv. Powder. Technol. 8 (4), 269–277 (1997).

9. M. Alcala et al., J. Pharm. Sci. 99 (1), 336–345 (2010).

10. W.P. Findlay, G.R. Peck, and K.R. Morris, J. Pharm. Sci. 94 (3), 604–612 (2005).

11. P. Frake et al., Int. J. Pharm. 151 (1), 75–80 (1997).

12. S.G. Goebel and K.J. Steffens, Pharm. Industrie 60 (10), 889–895 (1998).

13. A.A. Kaddour and B. Cuq, Powder Technol. 190 (1–2), 10–18 (2009).

14. P. Luukkonen et al., J. Pharm. Sci. 97 (2), 950–959 (2008).

15. A. Tok et al., AAPS PharmSciTech 9 (4), 1083–1091 (2008).

16. J.F. Gamble, A.B. Dennis, and M. Tobyn, Pharm. Dev. Technol. 14 (3), 299–304 (2009).

17. M. Halstensen, P. de Bakker, and K.H. Esbensen, Chemom. Intell. Lab. Syst. 84 (1–2), 88–97 (2006).

18. S. Matero et al., Chemom. Intell. Lab. Syst. 97 (1), 75–81 (2009).

19. M. Whitaker et al., Int. J. Pharm. 205 (1–2), 79–91 (2000).

20. X.H. Hu, J.C. Cunningham, and D. Winstead, Int. J. Pharm. 347 (1–2), 54–61 (2008).

21. J. Huang et al., J. Pharm. Sci. 99 (7), 3205–3212 (2010).

22. T. Lipsanen et al., AAPS PharmSciTech. 9 (4), 1070–1077 (2008).

23. T. Narvanen et al., J. Pharm. Sci. 98 (3), 1110–1117 (2009).

24. T. Narvanen et al., Int. J. Pharm. 357 (1–2), 132-138 (2008).

Citation: When referring to this article, please cite it as "A. Burggraeve, T. Van Den Kerkhof, M. Hellings, J.P. Remon, C. Vervaet, T. De Beer, "Understanding Fluidized-Bed Granulation," Pharmaceutical Technology 35 (8) 63-67(2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here